Request Deal Involvement

BlackRock and RA Capital Management led a $100m Series C round in TScan Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Argot Partners

pr advisors

Argot Partners

or

Principals

6 DIMENSIONS CAPITAL

bidder

6 DIMENSIONS CAPITAL

PITANGO VENTURE CAPITAL

bidder

PITANGO VENTURE CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

GV (GOOGLE VENTURES)

bidder

GV (GOOGLE VENTURES)

BLACKROCK

bidder

BLACKROCK

BESSEMER VENTURE PARTNERS

bidder

BESSEMER VENTURE PARTNERS

LONGWOOD FUND

bidder

LONGWOOD FUND

NOVARTIS VENTURE FUND

bidder

NOVARTIS VENTURE FUND

TSCAN THERAPEUTICS

target

TSCAN THERAPEUTICS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - BlackRock and RA Capital Management led a $100m Series C round in TScan Therapeutics.